Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...
Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.
Masimo's long-time lawsuit over Apple Watch patent infringement has encountered another setback, as a U.S. District Court ...
Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive ...
A Previously Banned Apple Watch Health Feature Is Now Here to Stay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results